JS
Therapeutic Areas
Rise Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| R-3750 | Ulcerative Colitis | Phase 1 |
| R-2487 | Sjögren’s Disease | Phase 1 (Initiation announced) |
| R-5780 | Cancer (unspecified) | Phase 1 |
| Undisclosed | Rheumatoid Arthritis | Phase 1 (ongoing study) |